Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
LifeStance Health Group
LFST
LifeStance Health Group
Digital Advances Will Strain Mental Health Care Yet Recovery Awaits
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
06 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$6.50
17.1% undervalued
intrinsic discount
16 Aug
US$5.39
Loading
1Y
-16.6%
7D
-0.4%
Author's Valuation
US$6.5
17.1% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$6.5
17.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-397m
2b
2019
2021
2023
2025
2027
2028
Revenue US$2.0b
Earnings US$67.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
13.89%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$66.95m
Earnings '28
x
48.22x
PE Ratio '28
=
US$3.23b
Market Cap '28
US$3.23b
Market Cap '28
/
408.51m
No. shares '28
=
US$7.90
Share Price '28
US$7.90
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$6.49
Fair Value '25
